SAN DIEGO, CA, March 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire-- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company ...
Leading Diagnostic Healthcare Company Signs Contract Manufacturing Agreement in Order to Fulfill Sales of IgE and Lactoferrin DED Diagnostic Assays Until this agreement, the Company has been ...
SAN DIEGO, CA - January 20, 2026 (NEWMEDIAWIRE) - AXIM Biotechnologies, Inc. ("AXIM" or the "Company") (OTC:AXIM), a diagnostic and biotechnology company advancing clinically validated solutions for ...
SAN DIEGO, July 21, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting ocular surface ...
Leading Diagnostic Healthcare Company Also Announces Over 50 Initial Clinic Commitments for Its Full Diagnostic Assay Platform The Company had previously announced the commencement of commercial ...
SAN DIEGO, Jan. 22, 2020 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological ...
SAN DIEGO, June 09, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM® Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological ...
AXIM Biotechnolgies, Inc. is beginning human dermatological clinical trials for Cannabinoid based solutions for psoriasis and eczema. The trials will be conducted at The Maurits Clinic in The Hague, ...
SAN DIEGO, Feb. 03, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results